Skip to content

IAN'S CORNER

Active
Private limited companyfounded 200125 yrs activeWijgmaalbroek 59, 3018 Leuven, BelgiumKBO/BCE: BE 0474.069.484
Summary

IAN'S CORNER has been active since 2001 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €288,817 and a net result of €4,209. Equity remains stable across the filed fiscal years (±1.5% per year). Its solvency ranks better than 60% of 9743 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).

Checked score

Score 2025
Axes · tick = 2024
Profitability70▼-2
Solvency89▲+1
Growth52=
Track record100
Bankruptcy probability, 12 months
0.2% Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €25,000 at 30 days acceptable
Liquidity ample (current ratio 7.19 against 6.0 in 2024; short-term debt: 9.9% and cash: 49.2% of total assets), and 35.8% of the assets are financed with debt.
Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 71
Relative position
BE, all sectors
reference
Architectural and engineering activities; technical testing and analysis (NACE 71)
about 56% fewer bankruptcies
← fewer bankruptcies more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 25 years 0 30 y
raises risk · Multiple establishment units
Several establishment units mean more fixed costs, and such companies fail more often than a company with one establishment.
KBO · establishment units
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
64.2%
Return on assets
0.9%
Age of the figures
18 mo
neutral · Filed after the deadline
The financial year that closed on 31-03-2025 was due by 31-10-2025 and was filed on 28-11-2025, 28 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filings
Deviation from the deadline
2025
28 d late
2024
on the day
2023
30 d late
2022
29 d late
2021
16 d late
2020
48 d late
2019
on the day
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 22 days after the deadline; the sector median for financial year 2024 is 8 days before the deadline, and 34% of the sector filed late.

Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-03-2026 and is due by 31-10-2026. Nothing is late today. Usually files around 28 November (5 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Position in the running window
31-03-2026 close01-10-2026 today31-10-2026 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

History

On 12 February 2001, IAN'S CORNER was incorporated.1 Total assets went from EUR 475,899 in 2019 to EUR 449,968 in 2025 and headcount from 0.6 full-time equivalents in 2019 to 1 in 2022.2

  1. 1Crossroads Bank for Enterprises
  2. 2National Bank, annual accounts 2019, 2022 and 2025

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.

Financials · fiscal year 2025, micro schema

Equity
€288,817▼ 0.9%
2024 · €291,558
Total assets
€449,968▼ 2.5%
2024 · €461,416
Net result
€4,209▼ 61.6%
2024 · €10,961
Working capital
€276,277▲ 3.5%
2024 · €266,952
Trend over the years
In euros
In per cent
Ratio
In full-time equivalents (FTE)
In euros
No line ticked in this group.
In per cent
No line ticked in this group.
Ratio
No line ticked in this group.
In full-time equivalents (FTE)
No line ticked in this group.

Untick a line to hide it. Point at a year (or use the arrow keys on the chart) for the exact figures; the table below gives them all.Sector: the middle half (P25 to P75) of NACE 71, Architectural and engineering activities; technical testing and analysis, each year against the same schema; no band under 30 filings. Dashed line: the median. Available for Net result, Equity, Total assets, Working capital, Solvency, Current ratio, Return on assets (ROA), Staff (FTE).

Every figure with its change against the fiscal year before
favourable unfavourable
Line20212022202320242025
Operating result€1,137€8,093▲ 612%€7,583▼ 6.3%€15,871▲ 109%€1,931▼ 87.8%
Net result€985below the sector's middle half€7,515within the sector's middle half▲ 663%€5,753within the sector's middle half▼ 23.5%€10,961within the sector's middle half▲ 90.5%€4,209within the sector's middle half▼ 61.6%
Equity€269,425above the sector's middle half▲ 0.4%€275,892above the sector's middle half▲ 2.4%€280,597above the sector's middle half▲ 1.7%€291,558above the sector's middle half▲ 3.9%€288,817above the sector's middle half▼ 0.9%
Total assets€439,602above the sector's middle half▼ 2.1%€448,133above the sector's middle half▲ 1.9%€442,615above the sector's middle half▼ 1.2%€461,416above the sector's middle half▲ 4.2%€449,968above the sector's middle half▼ 2.5%
Debt€170,177▼ 5.7%€172,241▲ 1.2%€162,018▼ 5.9%€169,858▲ 4.8%€161,152▼ 5.1%
Working capital€218,293above the sector's middle half▲ 7.3%€239,128above the sector's middle half▲ 9.5%€252,478above the sector's middle half▲ 5.6%€266,952above the sector's middle half▲ 5.7%€276,277above the sector's middle half▲ 3.5%
Solvency61.3%within the sector's middle half▲ 1.5pp61.6%within the sector's middle half▲ 0.3pp63.4%within the sector's middle half▲ 1.8pp63.2%within the sector's middle half▼ 0.2pp64.2%within the sector's middle half▲ 1.0pp
Current ratio5.68above the sector's middle half▲ 1.045.71above the sector's middle half▲ 0.046.55above the sector's middle half▲ 0.836.00above the sector's middle half▼ 0.547.19above the sector's middle half▲ 1.18
Return on assets (ROA)0.2%below the sector's middle half▲ 0.5pp1.7%within the sector's middle half▲ 1.5pp1.3%within the sector's middle half▼ 0.4pp2.4%within the sector's middle half▲ 1.1pp0.9%below the sector's middle half▼ 1.4pp
Staff (FTE)0.6=1▲ 66.7%
above within below the middle half (P25 to P75) of NACE 71, Architectural and engineering activities; technical testing and analysis, each year against the same schema; no band under 30 filings.
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
€0€5,000€10,000€15,000Operating result 2021: €1,137€1,137Net result 2021: €985€985Operating result 2022: €8,093€8,093Net result 2022: €7,515€7,515Operating result 2023: €7,583€7,583Net result 2023: €5,753€5,753Operating result 2024: €15,871€15,871Net result 2024: €10,961€10,961Operating result 2025: €1,931€1,931Net result 2025: €4,209€4,20920212022202320242025€0€5,000€10,000€15,000Operating result 2023: €7,583€7,580Net result 2023: €5,753€5,750Operating result 2024: €15,871€15,900Net result 2024: €10,961€11,000Operating result 2025: €1,931€1,930Net result 2025: €4,209€4,210202320242025
The operating result falls in 2025; 2025 is 88% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €449,968
Fixed assets €129,039 ▼ 8.6%
Current assets €320,929 ▲ 0.2%
Equity and liabilities €449,968
Equity €288,817 ▼ 0.9%
Debt €161,152 ▼ 5.1%
Debt's share of the balance-sheet total falls from 36.8% to 35.8%. Equity and debt are lower.
Key figures and ratios
2025 value · change against 2024
EBITDA
€15,913▼
2024 · €29,320
Cash flow
€18,191▼
2024 · €24,410
Quick ratio
5.00▲
2024 · 3.89
Debt to equity
0.56▼
2024 · 0.58
ROE
1.5%▼
2024 · 3.8%
Interest coverage
110.45▲
2024 · 70.14
Debt ≤ 1 year
€44,652▼
2024 · €53,358
Debt > 1 year
€115,000=
2024 · €115,000
Income taxes
€1,788▼
2024 · €4,775
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.

Peer companies

Historical observation

Of the 17,040 companies that looked in July 2024 the way this one looks now, 0.5% went bankrupt within 24 months and 94% are still going.

  • Micro
  • 20 years or older
  • solvency 30% or more
  • a profit under 5% of the balance sheet
0.5% went bankrupt
4.9% stopped otherwise
94% still going

A further 0.2% stopped, but we cannot tell whether within those 24 months.

For this company itself Checked computes a bankruptcy probability of 0.2% over twelve months; the group does not contradict it.

How reliable is this rule?

Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,341 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.

The companies in ten equal groups, from lowest to highest expected share.
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 3.0% 3.1%
10 5.6% 6.2%

The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.

An observation about 17,040 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.

Annual accounts
Filed annual accounts As filed with the NBB · 2025 against 2024 · 48 lines
Balance sheet Code20242025
Assets
Total assets20/58€461,416€449,968▼
Fixed assets21/28€141,106€129,039▼
Tangible fixed assets22/27€141,106€129,039▼
Land and buildings22€102,007€94,677▼
Plant, machinery and equipment23€39,099€34,362▼
Current assets29/58€320,310€320,929▲
Stocks and contracts in progress3€112,484€97,891▼
Stocks30/36€112,484€97,891▼
Amounts receivable within one year40/41€148-
Trade receivables40€148-
Current investments50/53€130,000-
Cash at bank and in hand54/58€75,932€221,510▲
Deferred charges and accrued income490/1€1,746€1,528▼
Equity and liabilities
Total equity and liabilities10/49€461,416€449,968▼
Equity10/15€291,558€288,817▼
Contributions10/11€200,000€200,000=
Outside capital11€200,000€200,000=
Other1109/19€200,000€200,000=
Reserves13€91,558€88,817▼
Non-distributable reserves130/1€10,025€10,025=
Reserves not available under the articles1311€10,025€10,025=
Distributable reserves133€81,533€78,792▼
Amounts payable17/49€169,858€161,152▼
Amounts payable after more than one year17€115,000€115,000=
Financial debts170/4€115,000€115,000=
Amounts payable within one year42/48€53,358€44,652▼
Trade debts44€1,965€127▼
Suppliers440/4€1,965€127▼
Taxes, remuneration and social security45€7,608€5,270▼
Taxes450/3€7,608€3,950▼
Remuneration and social security454/9-€1,320
Other amounts payable47/48€43,785€39,255▼
Accrued charges and deferred income492/3€1,500€1,500=
Income statement Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€13,449€13,983▲
Other operating charges640/8€3,647€2,695▼
Gross operating margin9900€32,967€18,608▼
Operating profit (loss)9901€15,871€1,931▼
Financial income75/76B€283€4,210▲
Recurring financial income75€283€4,210▲
Financial charges65/66B€418€144▼
Recurring financial charges65€418€144▼
Profit (loss) for the period before taxes9903€15,736€5,996▼
Income taxes67/77€4,775€1,788▼
Profit (loss) for the period9904€10,961€4,209▼
Profit (loss) for the period to be appropriated9905€10,961€4,209▼
Appropriation of the result
Profit (loss) to be appropriated9906€10,961€4,209▼
Transfer to equity691/2€10,961€4,209▼
To other reserves6921€10,961€4,209▼

The notes to these accounts (7 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line20212022202320242025Change
Non-recurring operating income76A-€47,496----
Remuneration, social security and pensions62-€2,279€670---
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€16,106€18,243€13,645€13,449€13,983▲ 4.0%
Other operating charges640/8-€1,719€1,774€3,647€2,695▼ 26.1%
Non-recurring operating charges66A-€10,504----
Gross operating margin9900€27,587€40,838€23,672€32,967€18,608▼ 43.6%
Operating profit (loss)9901€1,137€8,093€7,583€15,871€1,931▼ 87.8%
Financial income75/76B-€364€17€283€4,210▲ 1,387%
Recurring financial income75€174€364€17€283€4,210▲ 1,387%
Financial charges65/66B-€158€326€418€144▼ 65.5%
Recurring financial charges65€92€158€326€418€144▼ 65.5%
Profit (loss) for the period before taxes9903€1,219€8,300€7,274€15,736€5,996▼ 61.9%
Income taxes67/77€234€784€1,521€4,775€1,788▼ 62.6%
Profit (loss) for the period9904€985€7,515€5,753€10,961€4,209▼ 61.6%
Profit (loss) for the period to be appropriated9905€985€7,515€5,753€10,961€4,209▼ 61.6%
Line20212022202320242025Change
Assets
Total assets20/58€439,602€448,133€442,615€461,416€449,968▼ 2.5%
Fixed assets21/28€174,632€158,263€144,619€141,106€129,039▼ 8.6%
Tangible fixed assets22/27€174,632€158,263€144,619€141,106€129,039▼ 8.6%
Land and buildings22-€116,667€109,337€102,007€94,677▼ 7.2%
Plant, machinery and equipment23-€41,597€35,282€39,099€34,362▼ 12.1%
Current assets29/58€264,970€289,870€297,996€320,310€320,929▲ 0.2%
Stocks and contracts in progress3€220,580€149,259€112,484€112,484€97,891▼ 13.0%
Stocks30/36-€149,259€112,484€112,484€97,891▼ 13.0%
Amounts receivable within one year40/41€6,780€5,053€1,770€148--
Trade receivables40-€5,053€1,770€148--
Current investments50/53---€130,000--
Cash at bank and in hand54/58€35,971€134,212€182,275€75,932€221,510▲ 192%
Deferred charges and accrued income490/1-€1,346€1,467€1,746€1,528▼ 12.5%
Equity and liabilities
Total equity and liabilities10/49€439,602€448,133€442,615€461,416€449,968▼ 2.5%
Equity10/15€269,425€275,892€280,597€291,558€288,817▼ 0.9%
Contributions10/11-€200,000€200,000€200,000€200,000=
Outside capital11---€200,000€200,000=
Other1109/19---€200,000€200,000=
Reserves13€69,514€75,892€80,597€91,558€88,817▼ 3.0%
Non-distributable reserves130/1-€9,710€10,025€10,025€10,025=
Reserves not available under the articles1311-€9,710€10,025€10,025€10,025=
Distributable reserves133-€66,182€70,572€81,533€78,792▼ 3.4%
Profit (loss) carried forward14-€89-----
Amounts payable17/49€170,177€172,241€162,018€169,858€161,152▼ 5.1%
Amounts payable after more than one year17€122,000€120,000€115,000€115,000€115,000=
Financial debts170/4-€120,000€115,000€115,000€115,000=
Amounts payable within one year42/48€46,677€50,741€45,518€53,358€44,652▼ 16.3%
Trade debts44€1,008€10,610-€1,965€127▼ 93.5%
Suppliers440/4-€10,610-€1,965€127▼ 93.5%
Taxes, remuneration and social security45-€5,742€5,884€7,608€5,270▼ 30.7%
Taxes450/3-€4,123€5,884€7,608€3,950▼ 48.1%
Remuneration and social security454/9-€1,619--€1,320-
Other amounts payable47/48-€34,390€39,634€43,785€39,255▼ 10.3%
Accrued charges and deferred income492/3-€1,500€1,500€1,500€1,500=
Line20212022202320242025Change
Profit (loss) for the period9904€985€7,515€5,753€10,961€4,209▼ 61.6%
+ Depreciation and write-downs630€16,106€18,243€13,645€13,449€13,983▲ 4.0%
Operating cash flow (approximation)€17,091€25,759€19,398€24,410€18,191▼ 25.5%
Investment in fixed assets (approximation)--€1,875€0-€9,936-€1,916▲ 80.7%
Change in cash-€98,241€48,063-€106,343€145,578▲ 237%

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-10-2026
2026
15-09
State Gazette act Reappointments: Jan Vanhoof (statutory director) and Godelieve Lammens (plaatsvervangend statutair bestuurder)
Appointments: Jan Justina Peter VANHOOF, Godelieve Jeannre Lammens and 3 others · Legal-form conversion · Capital conversion18 facts ▸
  • General meeting, 26-08-2026
  • Legal-form conversion, besloten vennootschap
  • Capital conversion, statutair onbeschikbare eigen vermogensrekening
  • Reserve release, statutair onbeschikbare eigen vermogensrekening, opheffen
  • Purpose change
  • Statutes amendment
  • Director reappointment, Jan Vanhoof (statutory director)
  • Director reappointment, Godelieve Lammens (plaatsvervangend statutair bestuurder)
  • Capital
  • Director appointment, Jan Justina Peter VANHOOF (statutory director)
  • Director appointment, Godelieve Jeannre Lammens (statutory director)
  • Director appointment, Godelieve Lammens (non-statutory director)
  • +6 further facts in this act
2025
28-11
NBB filing Annual accounts filed
fiscal year 2025 · micro schema · 28 days late
2024
31-10
NBB filing Annual accounts filed
fiscal year 2024 · micro schema
2023
30-11
NBB filing Annual accounts filed
fiscal year 2023 · micro schema · 30 days late
2022
29-11
NBB filing Annual accounts filed
fiscal year 2022 · micro schema · 29 days late
2021
16-11
NBB filing Annual accounts filed
fiscal year 2021 · micro schema · 16 days late
31-03
Financial Back to profitnet €985
Net result €985 after one loss-making year.
2020
18-12
NBB filing Annual accounts filed
fiscal year 2020 · micro schema · 48 days late
31-03
Financial Weakest financial yearnet -€1,074
Net result drops to -€1,074, the lowest in the series; recovery starts the following year.
2019
31-10
NBB filing Annual accounts filed
fiscal year 2019 · micro schema
2018
17-10
NBB filing Annual accounts filed
fiscal year 2018 · micro schema · 17 days late
2017
29-09
NBB filing Annual accounts filed
fiscal year 2017 · micro schema
2016
28-09
NBB filing Annual accounts filed
fiscal year 2016 · abbreviated schema
Financial milestoneState Gazette actNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
1 of 5 acts read
About the unread acts

Of the 5 Belgian State Gazette acts we know for this company, 1 has been read. The other 4 have not been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Directors · office · real estate

Directors
under verification, last change in 2026
This board is reconstructed from a single act (26361670). A Gazette act generally publishes only CHANGES, not a full roll call, so directors unchanged since then may be missing here. The KBO register holds the complete list of function holders.
Bob Vanhoof
Non-statutory director · since 15-09-2026
Current
Bram Vanhoof
Non-statutory director · since 15-09-2026
Current
Godelieve Jeannre Lammens
Statutory director · since 15-09-2026
Current
Godelieve Lammens
Non-statutory director · since 15-09-2026
Current
Jan Justina Peter VANHOOF
Statutory director · since 15-09-2026
Current
Jan Vanhoof
Statutory director
Current
Derived from published Gazette acts. The CBE keeps the official list of function holders; we do not read it, so the two can differ. See the function holders in the CBE →
Not every act has been read: a resignation may be missing here
4 of this company's 5 Belgian State Gazette acts have not been read yet. Appointments and resignations recorded in them are missing above: a director who resigned there may therefore still show here as sitting. The acts are in the Timeline.
Location & real-estate footprint
Registered office, Leuven · 2 establishment units since 2001
seat establishment All 2 establishment units on the map
Ground area
3,166 m²
Building footprint
514 m²
Volume, LiDAR
2,222 m³
2 parcels, Flanders · tallest building 8.1 m, ±2 floors. Linked by address, not a title deed.
2 companies at this address See who is registered here
2 establishment units
Wijgmaalbroek 59, 3018 Leuven
Manufacture of basic metals
since 20012.097.836.816
Ian's Corner departement Lutherie Leuven
Wijgmaalbroek 51, 3018 LeuvenOther manufacturing
since 20182.275.197.257
2 parcels
Flanders 2 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
24038B0226/00H000 Flanders 2,358 m² 1 · 170 m² 8.1 m · 2 fl.
24038B0223/00P000 Flanders 808 m² 1 · 344 m² 6.0 m · 1 fl.
Linked by address, not proof of ownership
Good to know
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Mandate history

6 people since 2026, 6 in office
Show
  • Board
  • began earlier
Mandates per person, with start and end dates
Name Functions and periods
Bob Vanhoof
  • Non-statutory director, from 15-09-2026 to date
Bram Vanhoof
  • Non-statutory director, from 15-09-2026 to date
Godelieve Jeannre Lammens
  • Statutory director, from 15-09-2026 to date
Godelieve Lammens
  • Non-statutory director, from 15-09-2026 to date
Jan Justina Peter VANHOOF
  • Statutory director, from 15-09-2026 to date
Jan Vanhoof
  • Statutory director, already before 15-09-2026 to date
See the board, name and seat on a given date →

Articles of association

Who signs
“- iedere bestuurder vertegenwoordigt alléén de vennootschap tegenover derden en in rechte als eiser of verweerder tot een bedrag van € 8.000. Voor een bedrag hoger dan € 8.000 is de handtekening van minstens twee bestuurders vereist. Iedere bestuurder kan bijzondere machten toekennen aan elke…”
Full text

- iedere bestuurder vertegenwoordigt alléén de vennootschap tegenover derden en in rechte als eiser of verweerder tot een bedrag van € 8.000. Voor een bedrag hoger dan € 8.000 is de handtekening van minstens twee bestuurders vereist. Iedere bestuurder kan bijzondere machten toekennen aan elke mandataris.

Annual meeting
Purpose
17) het bestuderen, ontwerpen, ontwikkelen, prototypen, bouwen, kopen, verkopen, leasen en exploiteren van volledige of gedeeltes van elektriciteitscentrales, inclusief nucleaire…
Full purpose (25 activities)
  1. 17) het bestuderen, ontwerpen, ontwikkelen, prototypen, bouwen, kopen, verkopen, leasen en exploiteren van volledige of gedeeltes van elektriciteitscentrales, inclusief nucleaire reactoren, acceleratoren, stoomgeneratoren, warmtewisselaars, koelsystemen, turbines, condensors, alternators, transformatoren, omzetters, schakelaars, meetsystemen, veiligheidssystemen, meet-, regel- en beheerssoftware, en alle apparatuur voor de interconnectie van elektriciteitscentrales aan het Belgische hoogspanningsnet of aan internationale hoogspanningsnetten;
  2. 18) het verwerven, vervoeren, stockeren, raffineren, verkopen, gebruiken en exploiteren van strategische voorraden monazite, en alle andere materialen, inclusief radioactieve, en nucleair afval, die kunnen gebruikt worden of nodig zijn als nucleaire brandstoffen of hulpstoffen, constructiematerialen, koelstoffen, moderatoren, reflectoren en veiligheidsmantels;
  3. 19) het verwerven, het oprichten, inrichten en exploiteren van nucleaire laboratoria, inclusief het experimenteren met radioactief materiaal;
  4. 20) onderzoek naar de farmaceutische bruikbaarheid, effectiviteit en veiligheid van medische isotopen, zowel in vitro als in vivo, in het bijzonder, maar niet gelimiteerd tot, neutron-rijke isotopen voor Targeted Radionuclide Therapy (TRT) toepassingen en in vivo neutron-geactiveerde therapeutische en diagnostische isotopen;
  5. 21) het ontwikkelen van kleine, autonome nucleaire reactoren voor de on-site productie van medische isotopen voor onder andere zeer korte halftijden;
  6. 22) het ontwikkelen van compacte neutronenbronnen voor energetische, industriële en medische toepassingen, met inbegrip van fusors en andere kernfusie-gebaseerde bronnen op basis van gasvormige, vloeibare en solid-state materialen en van neutronreflectoren en neutroncollimatoren en neutronenergetische filters;
  7. 23) het uitvoeren en het assisteren in het uitvoeren en adviseren van klinische studies en het ontwerpen ervan, al dan niet met betrekking tot radioactieve farmaceutica, met focus op, maar niet gelimiteerd tot, de peri-operatieve behandeling binnen thoracale oncologie;
  8. 24) het leveren van advies en het geven van lessenreeksen en concultancy over medische praktijken, voornamelijk maar niet gelimiteerd tot toepassingen van radioactieve farmaceutica en gerelateerde chirugische ingrepen,met focus op, maar niet gelimiteerd tot, thoracale oncologische heelkunde;
  9. 25) het publiceren en verkopen van onderzoeksresultaten en exploitatieresultaten van bovengenoemde onderzoeken en acties, en het geven van lezingen;
  10. 26) het octrooieren van alle onderzoeksresultaten en exploitatiekennis en gerelateerde intellectuele eigendommen resulterend uit bovengenoemde onderzoeken en acties, inbegrepen alle acties nodig voor het beschermen van strategische kennis;
  11. 27) het uitvoeren van projectwerk voor derden, inclusief programmering en toepassing van informatica-systemen in de meest ruime zin;
  12. 28) het ontwerpen en exploiteren van een systeem voor energieverkoop, inbegrepen elektriciteit en synthetische brandstoffen, inclusief via E-commerce;
  13. 29) consulting, engineering, adviesverlening, dienstverlening, opleiding, ontwikkeling en implementatie onder meer rechtstreeks of onrechtstreeks verband houdend met nucleaire fysica en engineering, thermodynamica, vloeistoffenmechanica, klassieke mechanica, sterkteleer, klassieke en nucleaire materiaalkunde, elektronica, kwantumfysica, relativiteitstheorie, sterkstroom, nanotechnologie, informatica, software en informatietechnologie in de meest ruime zin en dit in hoofdzaak toegespitst op energieproductie en energiedistributie in de meest ruime zin;
  14. 30) het participeren in, en het aangaan van internationale samenwerkingsverbanden en uitwisselingsprojecten, inclusief internationale joint ventures met private en publieke organisaties en bedrijven met complementair en compatibele doelstellingen;
  15. 31) het verwerven en behouden van alle noodzakelijke nucleaire licenties;
  16. 32) het verwerven en behouden van alle noodzakelijke veiligheidslicenties;
  17. 33) het verwerven en behouden van alle noodzakelijke kwaliteitslabels;
  18. 34) het consulteren in de ontwikkeling van een volledig nieuw wettelijk kader voor de nucleaire energieconversie, inclusief veiligheidseisen en eisen met betrekking tot het produceren en behandelen van nucleair afval;
  19. 35) het uitvoeren van alle wettelijk toegestaan lobbywerk in de energiesector;
  20. 36) alle activiteiten in verband met muziekinstrumenten in de meest ruime zin. Dit omvat onder meer het ontwerpen, analyseren, schatten, onderzoeken, bouwen, ombouwen, verbeteren, afstellen, herafstellen, onderhouden, restaureren, verhuren, kopen en verkopen, al dan niet in consignatie, van muziekinstrumenten;
  21. 37) het adviseren als expert over instrumenten en het assisteren bij aankoop en verkoop ervan;
  22. 38) het organiseren van concerten en happenings voor het promoten van instrumenten en muziek;
  23. 39) het spelen op instrumenten en het maken van opnames;
  24. 40) het publiceren over muziek en instrumenten en het verkopen van literatuur en opnames;
  25. 41) het oprichten en management van en het zaakvoeren en investeren in winkels en bedrijven bedoeld voor de uitoefening van bovenstaande activiteiten, die tevens via het internet kunnen worden uitgeoefend.
Name clause
Registered office clause
Share issue rule
Bij hun uitgifte, volgestort
Share class
Op naam, voorzien van een volgnummer
Board rule
Benoemd met of zonder beperking van duur, één of meer bestuurders, natuurlijke personen of rechtspersonen, al dan niet aandeelhouder
Iedere bestuurder kan bijzondere machten toekennen aan elke mandataris., - iedere bestuurder vertegenwoordigt alléén de vennootschap tegenover derden en in rech…
Artikel 13. Vergoeding van de bestuurders
Other statement
Individueel of gezamenlijk, Dagelijks bestuur
Artikel 17. Toegang tot de algemene vergadering
Verdaging, geen afbreuk aan andere besluiten
Voting rule
Artikel 19. Beraadslagingen
Profit allocation
Artikel 22. Bestemming van de winst – reserves
Dissolution rule
Beslissing algemene vergadering, vormen vereist voor statutenwijziging
Liquidation rule
Artikel 24. Vereffenaars
Liquidation distribution
Goederen in natura op dezelfde wijze verdeeld, na aanzuivering schulden of consignatie

Structure & network

Connections & network

6 current directors
Depth

The network starts from this company’s directors. Other companies they run appear here as nodes.

This company Company Director Shareholding +N: links not shown yet Click a node to look further, drag to arrange, scroll to zoom.

Capital and shareholders

Capital over the years
  1. 15-09-2026 Converted to unavailable equity · 200,000 EUR

Similar companies · same sector, comparable size

Of 11,567 companies in this sector we hold annual accounts for 6,567. 4,907 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector

Company details

Identification
Legal formPrivate limited company
Founded12-02-2001
Fiscal year end31-03
Activities, NACEBEL 2025
71121Engineering and related technical consultancy, excluding land surveyors
32200Other manufacturing
E-invoicing
Reachable via Peppol
Peppol ID 0208:0474069484
Registered 16-06-2026

If you follow this company, Checked tells you the day it leaves the Peppol register.

Register as of 1 October 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.